Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 312 participants.

Also called NCT07273994

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 312 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07273994
  • EU CT 2024-514113-35-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07273994. Randomized; no masking; primary purpose treatment. Start 2025-11-01 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
Acronym
PERIVERSION-2
Condition
Persistent Atrial Fibrillation
Intervention (Drug)
Amiodarone Hydrochloride 200 MG
Intervention (Drug)
Amiodarone Hydrochloride 100 MG
Lead sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (class: other)
Collaborator
Instituto de Salud Carlos III (class: other government)

Record details

Record id
cardio:ct-nct07273994
Content hash
64499a8a074d05b3b81b95b70be1968bfcb386c016614db3c09cfadd5d45759a